The role of angiogenesis in the spread of oral squamous cell carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 34, Issue 1, 1996, Pages 37-41

  Penfold, C N ^a   Partridge, M ^c   Rojas, R ^b   Langdon, J D ^c  

^a QUEEN VICTORIA HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD31 ANTIGEN;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; MICROVASCULATURE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

EID: 0030064376     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(96)90133-3     Document Type: Article

References (20)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
3. Gimbrone MA, Cotran RS, Leapman SC, et al. Tumour growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974; 52: 413-427.
4. Garbett PK, Gibbins JR. Experimental neovascularization in vivo: the early changes in a stable adult vasulature responding to angiogenic stimulation by a syngenic neoplasm. Br J Exp Pathol 1987; 68: 625-635.
5. Liotta L, Kleinerman J, Saldel G. Quantitative relationships of intravascular tumour cells, tumour vessels, and pulmonary metastases following tumour implantation. Cancer Res 1974; 34:997-1004.
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
7. Horak ER, Leek R, Klenk N et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120-1124.
8. Srivastava A, Laidler P, Davies R et al. The prognostic significance of tumour vascularity in intermediate thickness (0.76-0.4 mm thick) skin melanoma. Am J Pathol 1988; 133: 419-423.
9. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 1994; 32(6): 588-594.
10. Parums DV, Cordell JL, Micklem K, Heryst AR, Gatter KC, Mason DV. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990; 43: 752-757.
11. Evans SJW, Langdon JD, Rapidis AD, Johnson NW. Prognostic significance of STNMP and velocity of tumour growth in oral cancer. Cancer 1982; 49: 773-776.
12. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato D. Vascular endothelial growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 1991; 88: 5819-23.
13. Almeida BM, Challacombe SJ, Eveson JW, Morgan PR, Purkis PE, Leigh IM. The distribution of LH39 basement membrane epitope in the tumour stroma of oral squamous cell carcinomas. J Pathol 1992; 166: 369-374.
14. Nagy JA, Brown LF, Senger DR et al. Pathogenesis of tumour stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochem Biophys Acta 1989; 948: 305-326.
15. Moscatelli D, Gross JL, Rifkin DB. Angiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells. J Cell Biol 1981; 91: 201a.
16. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 1991; 27: 781-784.
17. Bicknell R, Harris AL. Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Semin Cancer Biol 1992; 3: 399-407.
18. Harris AL, Fox S, Bicknell R, Leek R, Relf M, Lejune S, Kaklamanis L. Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer 1994; Supplement 74(3): 1021-1025.
19. Hori A, Sasada R, Matsutani E. Suppression of solid tumour growth by immunoneutralizing monoclonal antibody against basic fibroblast growth factor. Cancer Res 1991; 51: 6180-84.
20. Kim KJ, Li B, Winer J. Inhibition of vascular endothelial growth factor - induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-44.